Testimonials

medwriting“Your significant and continuous support made it possible to submit high quality manuscripts, and this, in due time.”
CEO, Biopharmaceutical Company, UK

biometrics_CRO_statistics“I recommend CROS NT to colleagues without hesitation. They are highly attentive, produce accurate quality work, and always make you feel you are their top customer. When I change company positions within the industry, CROS NT comes with me! I have worked successfully with CROS NT for the past 10 years!”
VP of Clinical Affairs, Medical Device company, USA

biometrics_CRO_pharma“We needed to execute and document SAS programming validation for statistical analyses we conducted for multiple Phase I studies. Due to frequent and effective communication with our CROS NT Services team, we were able to successfully complete the project in the desired time frame.”
Director of Biostatistics, Pharma company, USA

Biometrics_CRO_clinical_data_management“We have worked with CROS NT on a variety of projects and I have always found the level of support, as well as the adherence to committed timelines for deliverables, to be consistently excellent. This being said, CROS NT is very flexible and has always adapted to ever changing demands. Between the various staff I have worked with, from statisticians to project managers, I have found pleasant and professional personnel who are well trained technically.”
Global Head Statistical Programming, Vaccines Division, Pharma company, Italy

biometrics_CRO_biostatistics“During the past 10 years we have been collaborating on a regular basis with CROS NT both for a number of clinical projects, involving different products covering various therapeutic areas, on a national and international level. We have always appreciated and truly valued the friendly, respectful, considerate, generous and highly efficient approach with which CROS’ individuals offer their professional expertise.”
Clinical Research Senior Manager, Biotech company, Switzerland

biometrics_CRO_clinical_data“Our company has also worked with CROS NT on multiple Investigational Device Exemptions (IDEs) and major PMA Supplements. Their statisticians not only know the statistical methods that will be acceptable to FDA, they also know many of the reviewers and statisticians at the Center for Devices and Radiological Health (CDRH). The communication and negotiation skills have been a real asset to our projects. Our continued partnership on many of our major projects is the highest form of praise I can give CROS NT.”
President & CEO, Regulatory & Clinical Consulting company, USA